K469E polymorphism of the intercellular adhesion molecule-1 gene in Egyptians with coronary heart disease

<b>Background and Objectives:</b> The initial step in atherosclerosis is the adhesion of leukocytes to activated endothelial cells mediated by intercellular adhesion molecule-1 (ICAM-1). This study aimed to investigate the association of K469E polymorphism of the ICAM-1 gene and soluble...

Full description

Bibliographic Details
Main Authors: Mohamed Amal, Rashed Laila, Amin Hoda, Abu-Farha Manal, Abu El Fadl Soheir, Pakhoum Sameh
Format: Article
Language:English
Published: King Faisal Specialist Hospital and Research Centre 2010-01-01
Series:Annals of Saudi Medicine
Online Access:http://www.saudiannals.net/article.asp?issn=0256-4947;year=2010;volume=30;issue=6;spage=432;epage=436;aulast=Mohamed
Description
Summary:<b>Background and Objectives:</b> The initial step in atherosclerosis is the adhesion of leukocytes to activated endothelial cells mediated by intercellular adhesion molecule-1 (ICAM-1). This study aimed to investigate the association of K469E polymorphism of the ICAM-1 gene and soluble ICAM-1 (sICAM-1) serum level with coronary heart disease (CHD) in Egyptian subjects. <b>Patients and Methods:</b> Using a case-control design, we studied 100 patients with CHD, including 73 patients with acute myocardial infarction (MI) and 27 with unstable angina (UA). The control group consisted of 50 healthy subjects with normal left ventricular function. All participants were genotyped for the ICAM-1 polymorphism by the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. Serum sICAM-1 was measured by enzyme-linked immunoassay (ELISA). <b>Results:</b> In CHD patients, the frequencies of K genotype (KK and EK) were significantly higher when compared to controls (<i>P</i>&lt;.001) and were associated with an increased risk of disease development (OR=3.8, 95&#x0025; CI: 1.7 to 8.5; <i>P</i>=.001). K genotype frequencies in patients with MI showed no significant difference when compared to patients with UA (<i>P</i>= .121). Serum sICAM-1 levels were comparable between CHD patients and controls (<i>P</i>= .37) and between MI and UA patients (<i>P</i>=.23). There were no significant differences in sICAM-1 levels among patients with different genotypes (<i>P</i>=.532). Men presented with higher sICAM-1 levels than women (<i>P</i>=.004). <b>Conclusion:</b> ICAM-1 gene polymorphism in codon 469 is associated with a risk for CHD development in Egyptian subjects. Serum sICAM-1 is not influenced by this polymorphism and is not necessarily elevated in CHD.
ISSN:0256-4947
0975-4466